Eosinophilia and risk of incident end stage kidney disease

[1]  Haiqun Lin,et al.  Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritis. , 2019, JCI insight.

[2]  Lei Zhang,et al.  Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis. , 2017, Atherosclerosis.

[3]  H. Chiou,et al.  Risk factors of gender for renal progression in patients with early chronic kidney disease , 2016, Medicine.

[4]  C. Alpers,et al.  Interstitial eosinophilic aggregates in diabetic nephropathy: allergy or not? , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  Su-xia Wang,et al.  Assessment of KDIGO definitions in patients with histopathologic evidence of acute renal disease. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[6]  S. Nasr,et al.  Utility of urine eosinophils in the diagnosis of acute interstitial nephritis. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[7]  D. Sahani,et al.  Consensus statement on the pathology of IgG4-related disease , 2012, Modern Pathology.

[8]  C. Diskin,et al.  The prevalence and meaning of eosinophilia in renal diseases on a nephrology consultation service. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[10]  Stian Lydersen,et al.  Combining GFR and albuminuria to classify CKD improves prediction of ESRD. , 2009, Journal of the American Society of Nephrology : JASN.

[11]  P. Weller,et al.  Immunoregulatory roles of eosinophils: a new look at a familiar cell , 2008, Clinical and Experimental Allergy.

[12]  I. Bruce,et al.  Systemic lupus erythematosus, eosinophilic vasculitis and acalculous cholecystitis. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  F. Bahlmann,et al.  Life-Threatening Complications of Extracorporeal Treatment in Patients with Severe Eosinophilia , 2005, The International journal of artificial organs.

[14]  H. Liapis,et al.  Thrombotic microangiopathy associated with the hypereosinophilic syndrome. , 2005, Kidney international.

[15]  Philippe M. Gauthier,et al.  Abundance of Interstitial Eosinophils in Renal Allografts Is Associated with Vascular Rejection , 2005, Transplantation.

[16]  H. Kim,et al.  Eosinophilic Peritonitis in a Patient with Continuous Ambulatory Peritoneal Dialysis (CAPD) , 2004, The Korean journal of internal medicine.

[17]  A. Kosar,et al.  Eosinophilia in rheumatologic diseases: a prospective study of 1000 cases , 2004, Rheumatology International.

[18]  T. Erlinger,et al.  C-reactive protein and the risk of incident colorectal cancer. , 2004, JAMA.

[19]  P. Panina-Bordignon,et al.  Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells , 2004, European journal of immunology.

[20]  M. Inanç,et al.  Eosinophilia and hyperimmunoglobulinemia E as the presenting manifestations of Wegener’s granulomatosis , 2003, Clinical Rheumatology.

[21]  A. Hishida,et al.  Anti-glomerular basement membrane antibody—induced glomerulonephritis with periglomerular granulomatous reaction and massive renal eosinophilic infiltration , 2003 .

[22]  K. Iseki,et al.  Proteinuria and the risk of developing end-stage renal disease. , 2003, Kidney international.

[23]  J. Tomashefski,et al.  Peripheral blood eosinophilia in association with sarcoidosis. , 2000, Mayo Clinic proceedings.

[24]  M. Szklo,et al.  Epidemiology: Beyond the Basics , 1999 .

[25]  I. Roberts,et al.  Banff criteria as predictors of outcome following acute renal allograft rejection. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  C. Linassier,et al.  [Major circulatory and medullary eosinophilia revealing renal cell carcinoma]. , 1998, Presse medicale.

[27]  S. Prichard,et al.  Eosinophilic Peritonitis in Capd: Treatment with Prednisone and Diphenhydramine , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[28]  R. M. Martínez Álvarez,et al.  [Eosinophilia: initial presentation form of hypernephroma]. , 1997, Anales de medicina interna.

[29]  J. Savige,et al.  Classical polyarteritis nodosa and microscopic polyarteritis with medium vessel involvement--a comparison of the clinical and laboratory features. , 1997, Clinical nephrology.

[30]  K. Meyers,et al.  Eosinophilia as an early predictor of acute cellular rejection in pediatric renal transplants. , 1994, Transplantation proceedings.

[31]  V. Torres,et al.  Acute interstitial nephritis: immunologic and clinical aspects. , 1988, Mayo Clinic proceedings.

[32]  C. Charytan,et al.  Comparison of eosinophilia in patients undergoing peritoneal dialysis and hemodialysis. , 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  M. Hall-Craggs,et al.  The prognostic value of the eosinophil in acute renal allograft rejection. , 1986, Transplantation.

[34]  L. Vasaitis.  IgG4-related disease: A relatively new concept for clinicians. , 2016, European journal of internal medicine.

[35]  M. Moroni,et al.  Eosinophils and C4 predict clinical failure of combination immunotherapy with very low dose subcutaneous interleukin-2 and interferon in renal cell carcinoma patients. , 2000, Haematologica.

[36]  L. Guillevin,et al.  Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. , 1999, Medicine.